Fundraising FoxSamsara Therapeutics Inc.
Lewes, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Samsara Therapeutics Inc.
Sign up to find every way you can get introduced to Samsara Therapeutics Inc.
- Your email: who you already know at Samsara Therapeutics Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Samsara Therapeutics Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
Founders & leadership
JE
Jens EcksteinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.3M disclosed across 1 round · 2021
▶$10.3MraisedJul 2021 · 17 investors · BiotechnologyRule 506(b)
▶$10.3MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jens EcksteinExecutive Officer, Director
- Offering amount
- $12.7M
- Amount sold
- $10.3M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Samsara Therapeutics Inc. do?
- Biopharmaceutical company developing first-in-class therapeutics for rare genetic and neurodegenerative diseases with a focus on autophagy enhancement.
- Who are Samsara Therapeutics Inc.'s investors?
- Samsara Therapeutics Inc.'s investors include Korify Capital.
- How much funding has Samsara Therapeutics Inc. raised?
- Samsara Therapeutics Inc. has disclosed $10.3M raised across 1 round.
- Where is Samsara Therapeutics Inc. headquartered?
- Samsara Therapeutics Inc. is headquartered in Lewes, US.